Navigation Links
Quanterix Appoints Paul Chapman as President and Chief Executive Officer
Date:7/20/2012

LEXINGTON, Mass., July 20, 2012 /PRNewswire/ -- Quanterix Corporation, developer of the Single Molecule Array (Simoa) technology, announced today that it has appointed Paul Chapman as its new President and Chief Executive Officer.  Mr. Chapman joins the company at a pivotal time, as it moves from development to commercialization of its revolutionary digital ELISA platform that improves conventional immunoassay sensitivity 1000-fold.

"Quanterix's Simoa technology has the potential to dramatically change the world of biomarker research and clinical diagnostics," says Chapman.   "I am very excited to work with the exceptional team at Quanterix to make that potential a reality in the near future."

Prior to joining Quanterix, Mr. Chapman was Vice President of the BioPharm Process Solutions business at EMD Millipore where he was responsible for the Marketing and R&D teams in the $800 million business.   Prior to joining Millipore, he was the Vice President, Hospital Solutions for Roche Near Patient Testing in Austria, where he held P&L responsibility for Roche's decentralized Cardiac, Blood Gas / Electrolyte and Hospital Glucose businesses.  Mr. Chapman was also the International Business Development Manager at Roche Molecular Diagnostics for blood screening and, prior to that, held an array of sales and marketing positions at Roche Diagnostics Canada (where he began his career in 1993) focused primarily in the Molecular Diagnostics field.  Mr Chapman has a B.Sc. in Microbiology from the University of Western Ontario, a B.Sc (hons) in Immunology from the University of Guelph Ontario, and graduated from the Marketing Management Program (MMP) from the Richard Ivy School of Business.

"Paul is a visionary leader with a strong track record in several businesses and I have great confidence that he will make Quanterix a huge success," says Martin Madaus, Executive Chairman of the Board of Directors. "His background and capabilities to bring new technologies to market successfully make him uniquely qualified for Quanterix."  

Dr. Martin Madaus, who was previously CEO and Executive Chairman of the Board of Directors, will continue at Quanterix as the Executive Chairman, while Mr. Chapman takes the reins of the company's operations as President and Chief Executive Officer to prepare the organization for the launch of its first product in 2013. 

About Quanterix

Quanterix is a developer of ground-breaking tools in high definition diagnostics. Its Simoa platform uses single molecule measurements to access previously undetectable proteins. With this unprecedented sensitivity and full automation, Simoa offers significant benefits to both research and clinical testing applications. Quanterix was established in 2007 and is located in Lexington, Massachusetts.


'/>"/>
SOURCE Quanterix Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Conatus Pharmaceuticals Appoints Daniel Ripley As Head Of Corporate Development
2. ShangPharma Independent Committee Appoints Chairman and Legal Counsel
3. C3i Appoints Jonathan Song to Business Development Executive in Asia
4. Organovo Holdings Appoints James T. Glover to Board of Directors
5. Jennerex Appoints Dr. Laurent Fischer as President and Chief Executive Officer
6. ReShape Medical Appoints Robert E. Grant to Board of Directors
7. Nile Therapeutics Appoints Darlene Horton, M.D., as Chief Medical Officer
8. Stereotaxis Appoints William C. Mills III as Chairman of Board of Directors
9. Gentech Pharmaceutical Appoints New Medical Director for PhenTabz/ADDTabz
10. GenVec Appoints Cynthia Collins as President and CEO
11. Accuray Appoints Richard Pettingill, LFACHE to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/10/2017)... Global Health Intelligence (GHI), the leading healthcare data ... its 2017 ranking of the Best-Equipped Hospitals in Latin ... from GHI,s hospitals database for Latin America , which ... GHI database covers 86% of the hospitals in ... for each institution in key areas such as beds, medical ...
(Date:5/10/2017)... 2017 CSSi, the global leader in patient ... industry, is proud to announce the launch of its ... features both enriched content and a customized layout that ... company,s already well-established position as the top global patient ... many months of hard work, we are delighted to ...
(Date:5/9/2017)... , May 9, 2017  Oramed Pharmaceuticals ... ), a clinical-stage pharmaceutical company focused on the ... that the Canadian Intellectual Property Office has granted ... Oral Administration of Exenatide". The patent covers Oramed,s ... GLP-1 is an incretin hormone that ...
Breaking Medicine Technology:
(Date:5/26/2017)... ... May 26, 2017 , ... Amir Qureshi, MD is ... powerfully versatile, patient-centric spinal cord stimulation system. The Nuvectra™ Algovita SCS System has been ... pleased to be the first in Arkansas to introduce the most powerful SCS system ...
(Date:5/26/2017)... ... May 26, 2017 , ... On May 24, the Congressional Budget Office (CBO) ... House on May 4, would result in 23 million Americans losing their health insurance ... 2010 Patient Protection and Affordable Care Act (ACA). , “It is clear from ...
(Date:5/26/2017)... ... 26, 2017 , ... Dr. Alex Rabinovich, a highly-skilled oral surgeon specializing in ... post on insurance options. If a Bay Area patient has to search for a ... money. Visiting an in-network provider for a second opinion can ensure a patient receives ...
(Date:5/26/2017)... (PRWEB) , ... May 26, 2017 , ... “Cactus Jack: ... had on so many others. “Cactus Jack: Against All Odds” is the creation ... Walter D. Hubbard is married to Jack Carlisle’s third child Jane. Walter. ...
(Date:5/24/2017)... ... May 24, 2017 , ... Altec Products, ... in nVerge 2017 – a one-day technology conference in San Diego, CA. , ... which allows users to fully utilize and enhance their Sage ERP solutions by providing ...
Breaking Medicine News(10 mins):